Early stage resectable non-small cell lung cancer: is neoadjuvant immunotherapy the right way forward?
- PMID: 30631508
- PMCID: PMC6297455
- DOI: 10.21037/jtd.2018.10.22
Early stage resectable non-small cell lung cancer: is neoadjuvant immunotherapy the right way forward?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.N Engl J Med. 2018 May 24;378(21):1976-1986. doi: 10.1056/NEJMoa1716078. Epub 2018 Apr 16. N Engl J Med. 2018. PMID: 29658848 Free PMC article. Clinical Trial.
References
-
- SEER Cancer Stat Facts: Lung and Bronchus Cancer – [cited 2018 Aug 8]. Available online: https://seer.cancer.gov/statfacts/html/lungb.html
Publication types
LinkOut - more resources
Full Text Sources